Wegovy® release
- Q Med
- Jun 29, 2025
- 2 min read
Updated: Jul 3, 2025
Exciting News: Wegovy® Now Available in New Zealand!
We’re thrilled to announce that Wegovy® (semaglutide) has officially launched in New Zealand and we are proud to be one of the clinics offering this innovative medication to support your weight loss journey.
What is Wegovy®?
Wegovy® is a prescription medicine designed to help adults living with overweight or obesity achieve significant and sustainable weight loss. It works by reducing appetite and helping you feel fuller for longer, making it easier to adopt healthier lifestyle habits.
Why is this important?
This is the first time Wegovy® is available in New Zealand, bringing a new, effective option for patients seeking medically supervised weight management. Combined with diet, exercise, and support, Wegovy® can be a powerful tool to improve your health and wellbeing.
Is Wegovy® right for you?
If you have a BMI of 30 or higher, or 27+ with related health conditions such as type 2 diabetes or high blood pressure, you may be a candidate. Our team, fully trained in obesity management and experienced GLP-1 prescribers, will guide you through whether Wegovy® fits your treatment plan.
Want to learn more?
If you think Wegovy® might be right for you, contact us to book a consultation or ask any questions about Wegovy® and how it might help you reach your weight loss goals.
Our team is fully trained in obesity management and experienced GLP-1 prescribers.
Disclaimer:
Wegovy® (semaglutide) is a prescription medicine. Consult your doctor to determine if Wegovy® is right for you. Use strictly as directed. Wegovy® has risks and benefits. Always read the label and follow the instructions provided.
For more information, visit www.medsafe.govt.nz or consult your healthcare professional.
Sponsored by Qmed
Wegovy® is a registered trademark of Novo Nordisk A/S. This medication is available by prescription only and should be used under medical supervision.
For more information visit
Comments